Tethering of confactors on graphene-like materials

US9742011B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9742011-B2
Application numberUS-201414776777-A
CountryUS
Kind codeB2
Filing dateMar 17, 2014
Priority dateMar 15, 2013
Publication dateAug 22, 2017
Grant dateAug 22, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A family of customizable tethering molecules for tethering cofactors such as, but not necessarily limited to, nicotinamine adenine dinucleotide (NAD+/NADH, NAD(P)+/NAD(P)H) to substrates or structures formed from or including graphene-like materials is described. The tethered cofactor can then be used, for example, as biosensors employed for clinical diagnostic, food industry, medical drug development and environmental and military applications, as well as in reagentless biofuel cells for power generation.

First claim

Opening claim text (preview).

What is claimed is: 1. A complex formed from a NAD/(P)+/NAD(P)H cofactor tethered to a graphene-like material selected from the group consisting of multi-walled carbon nanotubes, single walled carbon nanotubes, graphene, rGO, and other graphene-based or graphene-containing substrates, wherein the cofactor is attached, via a covalent bond, to a pyrene butanoic acid succinimidyl ester tethering molecule which is attached to the graphene-like material via π-π stacking. 2. The complex of claim 1 wherein the graphene-like material is a multi-walled carbon nanotube (MWCNT). 3. The complex of claim 1 further comprising a protein which requires the presence of the cofactor for biological function tethered to the graphene-like material. 4. The complex of claim 3 wherein the protein is an enzyme. 5. The complex of claim 3 wherein the protein is a biocatalyst. 6. A method for forming a biological complex comprising: covalently attaching a NAD(P)+/NAD(P)H cofactor to a pyrene butanoic acid succinimidyl ester tethering enzyme and; attaching the tethering enzyme to a graphene-like material selected from the group consisting of multi-walled carbon nanotubes, single walled carbon nanotubes, graphene, rGO, and other graphene-based or graphene-containing substrates via π-π stacking. 7. The method of claim 6 further comprising tethering a protein that interacts with the NAD(P)+/NAD(P)H confactor to the graphene-like material. 8. The method of claim 7 wherein the protein is an enzyme. 9. The method of claim 7 wherein the protein is a biocatalyst.

Assignees

Inventors

Classifications

  • Dinucleotides, e.g. nicotineamide-adenine dinucleotide phosphate · CPC title

  • Multi-walled nanotubes · CPC title

  • Enzymes or microbial cells immobilised on or in an organic carrier · CPC title

  • Chemistry & Metallurgy · mapped topic

  • Selection of catalytic material · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9742011B2 cover?
A family of customizable tethering molecules for tethering cofactors such as, but not necessarily limited to, nicotinamine adenine dinucleotide (NAD+/NADH, NAD(P)+/NAD(P)H) to substrates or structures formed from or including graphene-like materials is described. The tethered cofactor can then be used, for example, as biosensors employed for clinical diagnostic, food industry, medical drug deve…
Who is the assignee on this patent?
Atanassov Plamen B, Narvaez Villarrubia Claudia W, Garcia Sergio Omar, and 1 more
What technology area does this patent fall under?
Primary CPC classification H01M4/9008. Mapped technology areas include Electricity.
When was this patent published?
Publication date Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).